Bio-Techne shareholders approve acquisition by Merck KGaA
Bio-Techne shareholders approved the acquisition by Merck KGaA, which is expected to close by late 2026 or early 2027, subject to regulatory conditions.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed